Israel Englander’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7M Buy
155,575
+5,669
+4% +$322K ﹤0.01% 2222
2026
Q1
$9.63M Buy
149,906
+83,951
+127% +$7.66M ﹤0.01% 2204
2025
Q4
$8.58M Buy
65,955
+14,217
+27% +$1.95M ﹤0.01% 2425
2025
Q3
$5.57M Buy
+51,738
New +$5.64M ﹤0.01% 3030
2025
Q2
Sell
-15,780
Closed -$1.4M 6382
2025
Q1
$1.4M Sell
15,780
-43,023
-73% -$3.73M ﹤0.01% 4104
2024
Q4
$4.52M Sell
58,803
-515,633
-90% -$36M ﹤0.01% 2902
2024
Q3
$24.4M Buy
574,436
+263,035
+84% +$8.88M 0.01% 1364
2024
Q2
$8.14M Buy
311,401
+205,318
+194% +$3.89M ﹤0.01% 2274
2024
Q1
$969K Sell
106,083
-26,275
-20% -$158K ﹤0.01% 4322
2023
Q4
$364K Buy
+132,358
New +$308K ﹤0.01% 4840
2023
Q3
Sell
-225,693
Closed -$1.35M 6628
2023
Q2
$1.35M Buy
+225,693
New +$1.79M ﹤0.01% 3804
2022
Q2
Sell
-20,340
Closed -$2.06M 7569
2022
Q1
$2.06M Sell
20,340
-9,711
-32% -$1.08M ﹤0.01% 3854
2021
Q4
$4.42M Buy
+30,051
New +$6.71M ﹤0.01% 3027
2021
Q3
Sell
-3,395
Closed -$1.57M 7311
2021
Q2
$1.57M Buy
3,395
+594
+21% +$255K ﹤0.01% 4232
2021
Q1
$1.38M Sell
2,801
-52,501
-95% -$27.3M ﹤0.01% 3879
2020
Q4
$20.1M Buy
+55,302
New +$19.3M 0.01% 1063

Other funds holding WGS

Israel Englander's WGS Position: Q2 2026 in Review

Israel Englander increased its GeneDx Holdings (WGS) stake by 3.8% in Q2 2026, buying an estimated $322K and bringing the position to 155,575 shares worth $10.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2222.

Israel Englander first reported a position in WGS in Q4 2020 and has held it in 16 quarters since. The position peaked at $24.4M in Q3 2024. 222 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Israel Englander held 155,575 shares of GeneDx Holdings worth $10.7M as of Q2 2026.
  • Israel Englander bought 5,669 GeneDx Holdings shares in Q2 2026, an estimated $322K.
  • GeneDx Holdings made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2222 holding.
  • Israel Englander first reported a position in GeneDx Holdings in Q4 2020 and has held it in 16 quarters since.
  • Israel Englander's GeneDx Holdings position peaked at $24.4M in Q3 2024.
  • 222 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.